6-6319115-C-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000129.4(F13A1):​c.-18-433G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.454 in 152,110 control chromosomes in the GnomAD database, including 16,412 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.45 ( 16412 hom., cov: 33)

Consequence

F13A1
NM_000129.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.386

Publications

1 publications found
Variant links:
Genes affected
F13A1 (HGNC:3531): (coagulation factor XIII A chain) This gene encodes the coagulation factor XIII A subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. It also crosslinks alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion. [provided by RefSeq, Jul 2008]
F13A1 Gene-Disease associations (from GenCC):
  • factor XIII, A subunit, deficiency of
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, ClinGen
  • congenital factor XIII deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.74 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
F13A1NM_000129.4 linkc.-18-433G>C intron_variant Intron 1 of 14 ENST00000264870.8 NP_000120.2 P00488
LOC124901253XR_007059428.1 linkn.55-10638C>G intron_variant Intron 1 of 1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
F13A1ENST00000264870.8 linkc.-18-433G>C intron_variant Intron 1 of 14 1 NM_000129.4 ENSP00000264870.3 P00488

Frequencies

GnomAD3 genomes
AF:
0.454
AC:
69007
AN:
151992
Hom.:
16413
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.552
Gnomad AMI
AF:
0.320
Gnomad AMR
AF:
0.460
Gnomad ASJ
AF:
0.463
Gnomad EAS
AF:
0.759
Gnomad SAS
AF:
0.483
Gnomad FIN
AF:
0.366
Gnomad MID
AF:
0.491
Gnomad NFE
AF:
0.383
Gnomad OTH
AF:
0.445
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.454
AC:
69041
AN:
152110
Hom.:
16412
Cov.:
33
AF XY:
0.458
AC XY:
34080
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.551
AC:
22883
AN:
41506
American (AMR)
AF:
0.460
AC:
7028
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.463
AC:
1607
AN:
3472
East Asian (EAS)
AF:
0.759
AC:
3932
AN:
5178
South Asian (SAS)
AF:
0.482
AC:
2318
AN:
4814
European-Finnish (FIN)
AF:
0.366
AC:
3866
AN:
10554
Middle Eastern (MID)
AF:
0.483
AC:
142
AN:
294
European-Non Finnish (NFE)
AF:
0.383
AC:
26038
AN:
67986
Other (OTH)
AF:
0.443
AC:
936
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1907
3814
5721
7628
9535
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
632
1264
1896
2528
3160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.403
Hom.:
1789
Bravo
AF:
0.464
Asia WGS
AF:
0.589
AC:
2046
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
2.3
DANN
Benign
0.53
PhyloP100
-0.39
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3024319; hg19: chr6-6319348; API